Package 72162-1515-3

{"route": ["ORAL"], "spl_id": "aedd747c-6f92-4721-95c2-5c793b3ad486", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["864V2Q084H", "0J48LPH2TH", "6M97XTV3HD"], "rxcui": ["1000001"], "spl_set_id": ["49ec5ac8-a626-4ab2-9799-8a138920201e"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (72162-1515-3)", "package_ndc": "72162-1515-3", "marketing_start_date": "20161026"}], "brand_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "product_id": "72162-1515_aedd747c-6f92-4721-95c2-5c793b3ad486", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "72162-1515", "generic_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA206137", "marketing_category": "ANDA", "marketing_start_date": "20161026", "listing_expiration_date": "20261231"}